A recent study has found that the diabetes medication Ozempic (semaglutide) is associated with a significant decrease in tobacco-related healthcare use. The research suggests that patients taking semaglutide experienced fewer healthcare visits related to smoking-related conditions, indicating a potential additional benefit of the drug beyond its primary use for diabetes management.

For more details, visit Reuters or Pharmaceutical Technology.